Chapter 3: The Price of Truth
The next forty-eight hours were a blur of high-stakes negotiations and clandestine meetings. We couldn't rely on the FBI this time—they were restricted by jurisdictional loopholes regarding the offshore patent.
"We have to go to the Board ourselves," Daniel said. "We have to show them that Margaret’s sale is illegal under international medical law."
The meeting at Vale Tower was intense. The Board members, once sycophants of Margaret, now looked like cornered animals. When I walked into the room, holding the black journals, the atmosphere shifted. I didn't need to speak; the weight of the secrets in my hands silenced them.
"This is the truth about the medical fraud," I announced, placing the journals on the long mahogany table. "And the patent she’s selling is based on stolen data from your own labs. If you sign off on this, you aren't just losing your reputation. You are going to prison."
The room erupted. Arguments broke out, papers flew, and the head of the Board tried to have us escorted out. But Daniel stood his ground, his authority as the rightful CEO—even in his weakened state—commanding the room.
"The merger is dead," Daniel declared. "And if you want to keep your pensions, you’ll help us freeze the offshore account."
As we walked out of the building, I felt a weight lift. But the drama wasn't finished. Outside, we were met not by reporters, but by a legal team led by an unfamiliar face—a woman who introduced herself as the executor of Margaret’s late husband’s true will.
"It seems," the woman said, "that Margaret’s control over the estate was based on a forged document from twenty years ago. The inheritance is being legally contested."
It was a final, desperate move by Margaret’s allies. They wanted to tie us up in litigation for the next decade.
May you like
"Let them," I said, catching Daniel’s eye.
We had enough. We had our lives, we had our daughter, and for the first time, we had the truth.
